Akoya Biosciences Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
330
- Stock Symbol
-
AKYA
- Investments
-
2
- Share Price
-
$2.78
- (As of Friday Closing)
Akoya Biosciences General Information
Description
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Contact Information
Website
www.akoyabio.comCorporate Office
- 100 Campus Drive
- 6th Floor
- Marlborough, MA 01752
- United States
Corporate Office
- 100 Campus Drive
- 6th Floor
- Marlborough, MA 01752
- United States
Akoya Biosciences Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.78 | $2.56 | $1.88 - $6.31 | $138M | 49.5M | 160K | -$1.22 |
Akoya Biosciences Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 139,177 | 235,970 | 347,260 | 482,406 |
| Revenue | 93,216 | 96,633 | 74,859 | 54,917 |
| EBITDA | (45,431) | (49,121) | (59,592) | (35,259) |
| Net Income | (60,351) | (63,323) | (70,641) | (42,935) |
| Total Assets | 143,745 | 180,369 | 176,031 | 190,907 |
| Total Debt | 84,698 | 85,706 | 75,784 | 32,940 |
Akoya Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Akoya Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Akoya Biosciences Comparisons
Industry
Financing
Details
Akoya Biosciences Competitors (19)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 10x Genomics | Private Equity-Backed | Pleasanton, CA | ||||
| Pacific Biosciences | Formerly VC-backed | Menlo Park, CA | ||||
| ProNova Solutions | Formerly VC-backed | Maryville, TN | ||||
| Ionpath | Venture Capital-Backed | Menlo Park, CA | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom |
Akoya Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Akoya Biosciences Patents
Akoya Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230130371-A1 | Rna detection by selective labeling and amplification | Pending | 03-Aug-2021 | ||
| US-20220364160-A1 | Amplification of rna detection signals in biological samples | Pending | 14-May-2021 | ||
| EP-4337787-A1 | Amplification of rna detection signals in biological samples | Pending | 14-May-2021 | ||
| US-20220316004-A1 | Detection of labeled analytes in biological samples | Pending | 06-Apr-2021 | ||
| EP-4320270-A1 | Detection of labeled analytes in biological samples | Pending | 06-Apr-2021 | C12Q1/6841 |
Akoya Biosciences Executive Team (15)
| Name | Title | Board Seat |
|---|---|---|
| Brian McKelligon | Chief Executive Officer & Board Member | |
| Johnny Ek | Chief Financial Officer | |
| Frederic Pla Ph.D | Chief Operating Officer, Operations | |
| Niro Ramachandran Ph.D | Chief Business Officer | |
| Yury Goltsev | Co-Founder |
Akoya Biosciences Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian McKelligon | Akoya Biosciences | Chief Executive Officer & Board Member | |
| Matthew Winkler Ph.D | Self | Board Member | |
| Myla Lai-Goldman MD | Self | Board Member | |
| Robert Shepler | Self | Chairman & Board Member | |
| Scott Mendel | Self | Board Member |
Akoya Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Akoya Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Akoya Biosciences Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PerkinElmer (Phenoptics portfolio) | 31-Oct-2018 | Buildings and Property | |||
| PerkinElmer (Quantitative Pathology Solutions Division) | 28-Sep-2018 | Merger/Acquisition | Laboratory Services (Healthcare) |
Akoya Biosciences ESG
Risk Overview
Risk Rating
Updated April, 01, 2023
31.84 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Pharmaceuticals
Industry
of 909
Rank
Percentile
Biotechnology
Subindustry
of 404
Rank
Percentile
Akoya Biosciences FAQs
-
When was Akoya Biosciences founded?
Akoya Biosciences was founded in 2015.
-
Who is the founder of Akoya Biosciences?
Yury Goltsev and Nikolay Samusik Ph.D are the founders of Akoya Biosciences.
-
Who is the CEO of Akoya Biosciences?
Brian McKelligon is the CEO of Akoya Biosciences.
-
Where is Akoya Biosciences headquartered?
Akoya Biosciences is headquartered in Marlborough, MA.
-
What is the size of Akoya Biosciences?
Akoya Biosciences has 330 total employees.
-
What industry is Akoya Biosciences in?
Akoya Biosciences’s primary industry is Other Healthcare Technology Systems.
-
Is Akoya Biosciences a private or public company?
Akoya Biosciences is a Public company.
-
What is Akoya Biosciences’s stock symbol?
The ticker symbol for Akoya Biosciences is AKYA.
-
What is the current stock price of Akoya Biosciences?
As of 04-Oct-2024 the stock price of Akoya Biosciences is $2.78.
-
What is the current market cap of Akoya Biosciences?
The current market capitalization of Akoya Biosciences is $138M.
-
What is Akoya Biosciences’s current revenue?
The trailing twelve month revenue for Akoya Biosciences is $93.2M.
-
Who are Akoya Biosciences’s competitors?
10x Genomics, Pacific Biosciences, ProNova Solutions, Ionpath, and Oxford Nanopore Technologies are some of the 19 competitors of Akoya Biosciences.
-
What is Akoya Biosciences’s annual earnings per share (EPS)?
Akoya Biosciences’s EPS for 12 months was -$1.22.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
